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Abstract
Macrophages are the first line of defense against pathogens. Upon infection macrophages usually produce high levels of
proinflammatory mediators. However, macrophages can undergo an alternate polarization leading to a permissive state. In
assessing global macrophage responses to the bacterial agent of Whipple’s disease, Tropheryma whipplei, we found that T.
whipplei induced M2 macrophage polarization which was compatible with bacterial replication. Surprisingly, this M2
polarization of infected macrophages was associated with apoptosis induction and a functional type I interferon (IFN)
response, through IRF3 activation and STAT1 phosphorylation. Using macrophages from mice deficient for the type I IFN
receptor, we found that this type I IFN response was required for T. whipplei-induced macrophage apoptosis in a JNK-
dependent manner and was associated with the intracellular replication of T. whipplei independently of JNK. This study
underscores the role of macrophage polarization in host responses and highlights the detrimental role of type I IFN during
T. whipplei infection.
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Introduction
Over the past decades, activated macrophages were mainly
considered as cells that secrete inflammatory mediators and kill
intracellular pathogens. However, studies have now revealed
activated macrophages as a continuum of cells with phenotypic
and functional heterogeneity [1,2]. Schematically, macrophages
exposed to the classic activation signals (lipopolysaccharide (LPS)
and/or IFN-c) polarize into the M1 phenotype and express high
levels of TNF, IL-1, IL-6, IL-12, type I IFN, inflammatory
chemokines, such as CXCL10, and inducible nitric oxide synthase.
In contrast, M2 macrophages, induced by IL-4, IL-10 or immune
complexes, are characterized by the expression of non-opsonic
receptors, arginase, and the absence of proinflammatory cytokines
[3,4]. Recently, we defined a ‘‘common host response’’ of
macrophages to bacterial infections, characterized with an M1
signature and associated with the control of acute infections.
However, successful infection by pathogenic intracellular bacteria
usually relies on the perturbation or avoidance of the classical M1
proinflammatory activation profile [3].
Recognition of microorganisms by macrophages is mediated by
pattern recognition receptors (PRR) that bind conserved microbe-
associated molecular patterns (MAMPs) [5]. PRR engagement by
MAMPs activates a major signaling cascade that leads ultimately
to the activation of mitogen-activated protein (MAP) kinases and
the transcription factors NF-kB and IRF3 [5,6]. These transcrip-
tion factors then migrate to the nucleus where they drive the
transcription of proinflammatory genes and type I IFN genes,
respectively [7]. Type I IFN are responsible for inducing
transcription of a subset of genes referred as interferon stimulated
genes. Classically, type I IFN transcription is first activated by
signals that induce cooperative binding of the transcription factors
c-Jun/ATF2, NF-kB and interferon regulatory factor-3 (IRF3) to
the promoter [8]. Following stimulation with viral or bacterial
components, the constitutively expressed IRF3 is phosphorylated
in the cytoplasm, dimerizes and then translocates in the nucleus to
induce the transcription of type I IFN [9]. Once secreted, type I
IFN initiates a positive feed-back loop through binding to its
receptor IFNAR [8]. IFNAR activates the protein tyrosine kinases
JAK1 and JAK2 which phosphorylate STAT1 and STAT2 to
further drive the transcription of a large group of IFN inducible
genes [10].
Stimulation with Gram-negative bacteria or LPS induces type I
IFN, at least partially through Toll-like receptor (TLR) 4 [11]. In
addition, the intracellular pathogens Shigella flexnerii, Legionella
pneumophila and Francisella tularensis induce a potent type I IFN
response while non invasive mutants do not [12–14]. MAMPs
from Gram-positive bacteria are also able to induce type I IFN.
Indeed, Listeria monocytogenes triggers type I IFN, probably through
bacterial DNA recognition by a cytosolic receptor [15,16].
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been shown to induce type I IFN [17]. Recently, the extracellular
pathogen group B Streptococcus has been shown to induce type I
IFN in a TLR-independent manner through intracellular
recognition of its DNA [18]. Remarkably, stimulation of
macrophages with most of these bacteria and/or bacterial ligands
induces M1 polarization, strongly supporting the fact that type I
IFN response is a feature of classical activation of macrophages.
This point is strengthened by the fact that type I IFN significantly
contribute to the cross-talk between the MyD88-dependent and
MyD88-independent pathways, enabling full responsiveness to
LPS [19].
Here, we have studied and characterized mouse macrophage
responses to infection with the facultative intracellular Gram
positive bacterium Tropheryma whipplei, the etiologic agent of
Whipple’s disease [20]. Whipple’s disease is a rare systemic disease
that associates arthropathy, weight loss and gastrointestinal
symptoms [21] but its pathophysiology remains largely unknown.
Recently, we provided major insights into the understanding of
host immune factors in Whipple’s disease, delineating macrophage
polarization and apoptosis as critical in the pathophysiology of the
disease [3,22–24]. In this report, we provide evidence that, besides
M2 macrophage polarization and apoptosis, T. whipplei induced a
robust type I IFN response. This response required bacterial
viability and was associated with bacterial intracellular replication.
We also observed that T. whipplei induced macrophage apoptosis
in a type I IFN- and JNK- dependent manner. These findings
reveal an unexpected type I IFN response associated with M2
polarization.
Results
Transcriptional program induced by T. whipplei
To evaluate gene expression profiles, bone marrow-derived
macrophages (BMDM) were infected with T. whipplei for 6 h and
transcriptional response was examined by microarray analysis. Of
the 43,379 spotted features, 356 were significantly modulated in
response to T. whipplei infection (P,0.01, Fig. 1A). To increase the
reliability of our datasets, we considered transcripts as significantly
regulated if they showed at least a 2-fold modulation in gene
expression levels. We overall identified 59 and 11 genes that were
up- and downregulated, respectively. Upregulated genes were
assigned to biological process gene ontology (GO) categories.
Around 50% of them belonged to the immune response GO group
(Fig. 1B). These immune response genes could be sub-classified in
4 functional categories. In the first category were genes linked to
macrophage polarization and more specifically to M2 polarization
(Fig. 1C). Indeed, genes for the prototypal M2 markers interleukin
1 receptor antagonist (il1rn) and arginase 2 (arg2), as well as the M2
chemokines Ccl17 and Ccl22 were induced, while none of the M1
markers were modulated. The second set of the immune response-
related genes represented genes related to PRR (Fig. 1C). In this
group, 2 genes encoding lectins were markedly induced: clec4e
which encodes a C-type lectin, and olr1, which encodes the lectin-
like oxidized low density lipoprotein receptor 1. In addition, T.
whipplei also upregulated the expression of tlr2, involved in the
recognition of Gram-positive bacteria, and that of formyl peptide
receptor 2, encoded by fpr2, which mediates the chemotactic
activity of a variety of pathogen and host-derived peptides. The
third group of immune response-associated genes included
apoptosis-related genes. Indeed, we found that fas, and tnfsf10
were efficiently induced in BMDM following stimulation with T.
whipplei (Fig. 1C). Finally, we isolated a fourth set of immune
response-related genes that contained genes involved in the type I
IFN response (Fig. 1C). In this group were found the genes
encoding Mx1 and Mx2, which mediate resistance against
negative-strand RNA viruses, but also the IFN-stimulated genes
ifit1, ifit2 and ifit3, also known as isg56, isg54 and isg49,
respectively. Three other IFN-inducible genes (irg1, ifi44 and
gbp2) were among the most induced genes by T. whipplei. Selected
genes were studied by quantitative real time RT-PCR. Upregula-
tion of these exemplary genes was confirmed and statistical
analysis revealed a significant correlation between microarray and
RT-PCR data (Table 1).
T. whipplei-induced M2 polarization is related to a weak
proinflammatory signaling and favors bacterial
replication
The transcriptional program of BMDM elicited by T. whipplei
revealed a marked polarization towards a M2 phenotype. This
macrophage functional activation state is characterized by the
absence of proinflammatory mediators [3]. We investigated the
lack of proinflammatory response by examining the activation of
the transcription factor NF-kB and the phosphorylation of MAPK
in response to T. whipplei.
NF-kB activation was assessed by determining changes in
cytoplasmic IkBa protein levels. LPS (100 ng/ml) clearly induced
NF-kB activation. Indeed, a transient degradation of IkBa,
maximal at 15 min was observed (Fig. 2A). This profile was in
agreement with kinetics of RelA translocation in the nucleus
(Fig. 2B). In contrast, stimulation with T. whipplei induced a faint
IkBa degradation between 1 h and 2 h and IkBa levels increased
back normal by 3 h (Fig. 2A). However, RelA translocation was
not observed, even by increasing 4 fold the dose of bacteria
(Fig. 2B). Nevertheless, the fact that IkBa increased back to initial
levels at 3 h suggest that T. whipplei is a weak activator of NF-kB.
Besides NF-kB, we assessed MAPK activation in response to T.
whipplei. BMDM were stimulated with 100 ng/ml LPS or T.
whipplei for 15 min to 3 h and, subsequently, analyzed for
phosphorylation of the MAPKs, p38, Erk1/2, and JNK. In the
first 15–30 min after LPS stimulation, transient phosphorylation of
all kinases could be detected (Fig. 2C). In contrast, when BMDM
were stimulated with T. whipplei, no phosphorylation of the
Author Summary
Innate immune cells are sentinels allowing the host to
sense invading pathogens. Among them, macrophages are
highly microbicidal and are able to kill microorganisms.
However, several pathogens have evolved strategies to
hijack macrophage responses in order to survive or
replicate. Tropheryma whipplei is the agent of Whipple’s
disease, a systemic disease that associates arthropathy,
weight loss and gastrointestinal symptoms. It has been
known for several years that this bacterium has a tropism
for macrophages, in which it replicates. In this study, we
have shown that T. whipplei induces host cell apoptosis
and a surprising macrophage activation, characterized by
anti-inflammatory molecules and type I interferon (IFN)
signaling, which is generally associated to viral infections.
We demonstrate that this type I IFN response is critical for
bacterial pathogenicity, as it is required for bacterial
replication and provides the first step of the apoptotic
program of infected macrophages. By identifying these
signaling events induced in macrophage by T. whipplei,w e
can now better understand the molecular basis of the
pathophysiology of Whipple’s disease, of interest for
clinical and therapeutic ends.
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time-frame (Fig. 2C). Increasing the doses of T. whipplei had no
effect on MAPK activation (data not shown).
As BMDM were poorly proinflammatory, it is likely that they
allowed T. whipplei replication. Therefore, BMDM were infected
with T. whipplei and bacterial uptake and replication was assessed
by qPCR. BMDM efficiently internalized T. whipplei as around
6,000 bacterial DNA copies were detected after 4 h of infection
(Fig. 3A). In the first 3 days, bacterial DNA copy number
decreased and started to increase after 6 days and reached around
30,000 copies after 12 days (Fig. 3A). These results were further
investigated by examining the vacuole containing T. whipplei at day
12 post infection. The great majority of bacteria colocalized with
the late phagosome marker lamp1 (92%611%); however, these T.
whipplei-containing vacuoles excluded the lysosomal hydrolase
cathepsin D (20%615%, Fig. 3B).
Figure 1. Transcriptional program induced T. whipplei in BMDM. BMDM were stimulated with T. whipplei (MOI 50:1) for 6 h and
transcriptional responses were monitored by microarrays. (A) Gene expression values were normalized by trimmed means followed by the unpaired
Student’s t test (P,0.01) and agglomerative hierarchical clustering of 356 spotted features was based on expression patterns between samples. Rows
colorimetrically represent expression values of individual genes from black (low expression) to red (high expression). (B) T. whipplei-regulated genes
were assigned functional categories by determining genes statistically over represented through Gene Ontology (GO) annotations. The diagram
displays all statistically relevant GO groups among the up-regulated genes. (C) Immune response GO group-belonging genes were then classified in
functional sub-categories after dividing gene expression values from T. whipplei-stimulated BMDM by expression values from mock-treated values to
derive fold change ratios.
doi:10.1371/journal.ppat.1000722.g001
Type I IFN during T. whipplei Infection
PLoS Pathogens | www.plospathogens.org 3 January 2010 | Volume 6 | Issue 1 | e1000722Overall, these results showed that T. whipplei infects BMDM,
induces M2 polarization and replicates, at least by interfering with
phagosome conversion.
Functional type I IFN signalling induced by T. whipplei
Besides M2 polarization, BMDM response profiling to T.
whipplei infection revealed a striking induction of type I IFN-
inducible genes. Some genes, among which ifnb1 and cxcl10, which
encode respectively IFN-b and the chemokine Cxcl10, were
excluded from the analysis when we applied our criterion;
however, ifnb1 was up-regulated 1.6 times and cxcl10 4.2 times.
To further confirm type I IFN induction following T. whipplei
infection, we performed time course experiments. Expression of
IFN-b mRNA increased to reach a maximal level at 6 h after
infection and then was shut off, as revealed by its low expression
value at 24 h (Fig. S1A). Consistent with transcriptional data, IFN-
b protein was secreted by infected BMDM at 3 h and reached
maximal levels 6 h post infection (Fig. S1B), exemplifying the
importance of the type I IFN pathway during T. whipplei infection.
Induction of IFN-b is thought to depend on the constitutively
expressed transcription factor IRF3 [9]. We therefore, determined
the subcellular localization of IRF3 following T. whipplei
stimulation. Raw 264.7 macrophages overexpressing EGFP-
IRF3 were incubated with T. whipplei for 4 h. Confocal microscopy
allowed to visualized a marked nuclear translocation of IRF3 in
Table 1. Validation of the microarray.
gene microarray qRT-PCR
irg1 6.7 7.1
olr1 6.7 2.9
ifi44 2. 9 2.2
mmp14 2.8 2.1
arg2 2.6 2.6
ccl17 2.3 3.2
ccl22 2.2 1.2
ifit2 2.1 2.0
ifit1 2.1 2.4
mx2 2.0 1.5
nfkbie 2.0 1.7
mx1 2.0 1.7
Microarray results were confirmed by qRT-PCR. Results are expressed as the
ratio of expression levels in infected cells vs. uninfected cells. For qRT-PCR, ratio
were calculated relative to beta actin control.
doi:10.1371/journal.ppat.1000722.t001
Figure 2. T. whipplei poorly induces NF-kB and MAPK pathways. (A) BMDM were stimulated with LPS (100 ng/ml) or T. whipplei (MOI 50:1) for
the indicated time points, and lysates were analyzed by immunoblotting. IkBa blots were stripped and reprobed for ERK as loading control. One
representative experiment is shown (n=3). (B) BMDM were stimulated for 1 h with LPS (100 ng/ml) or T. whipplei (MOI 50:1 or 200:1). RelA nuclear
translocation was determined by immunofluorescence using p65-specific antibodies. (C) BMDM were stimulated with LPS (100 ng/ml) or T. whipplei
(MOI 50:1) for the indicated time points, and lysates were analyzed by immunoblotting. Phospho-p38, phospho-ERK and Phospho-JNK blots were
stripped and reprobed for p38 and ERK as loading controls. One representative experiment is shown (n=3).
doi:10.1371/journal.ppat.1000722.g002
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remained in the cytosol. This result suggests that the type I IFN
induction depends on the transcription factor IRF3. To further
examine the role of IRF3 in type I IFN induction by T. whipplei,w e
used siRNA technology. Transfection of IRF3-specific siRNA (si-
IRF3) in Raw 264.7 macrophages resulted in a dramatic reduction
of IRF3 levels at 24 h (84%), as determined by Western blot, while
control scramble siRNA (si-SCR) had no effect (Fig. S2A). IRF3-
specific siRNA action was transient since IRF3 levels were back to
normal 48 h post transfection. Therefore, we selected the 24 h
time point to monitor the effect of IRF3 inhibition on IFN-b
expression. Inhibition of IRF3 led to a profound reduction of IFN-
b expression following T. whipplei stimulation, compared to control
siRNA (Fig. 4B). As a result, IFN-b production was reduced by
94% in cells lacking IRF3 (Fig. S2B), thus identifying IRF3 as a
component of the signalling pathway leading to type I IFN
induction by T. whipplei-infected macrophages.
In order to understand how T. whipplei turns on the type I IFN
response, we examined the potential contribution of TLRs, the
signalling of which is known to ultimately involve the adaptor
molecules MyD88 and/or TRIF [25]. BMDM from double
MyD88 and TRIF-deficient (MyD88/TRIF
2/2) mice, which are
unable to respond to TLR agonists, were stimulated with T.
whipplei and IFN-b expression was monitored by qRT-PCR.
Results showed that in contrast to wt BMDM, IFN-b expression
was abrogated in MyD88/TRIF
2/2 BMDM (Fig. 4C), suggesting
that TLR signalling is required for type I IFN response during T.
whipplei infection.
Next, we wondered whether T. whipplei induces IFN-inducible
genes via a type I IFN autocrine loop after engagement of the type
I IFN receptor [26]. Thus, we first monitored the activation of the
Stat1 transcription factor, one outcome of IFN secretion and type I
IFN receptor engagement [27]. STAT1 activation was measured
using specific antibodies targeting STAT1 phosphorylated at
tyrosine 701. As shown in Figure 4D, an increase in Stat1 Tyr701
phosphorylation after T. whipplei stimulation was evidenced at 6 h
with further elevation at 24 h and 48 h. In contrast, Stat1
phosphorylation was completely absent when BMDM knocked-
out for the type I IFN receptor gene (IFNAR1
2/2) were
stimulated with T. whipplei (Fig. 4D).
Subsequently, we analyzed the irg1, ifit1, ifit2, ifit3, mx1 and mx2
gene induction following T. whipplei stimulation in IFNAR1
2/2
BMDM. BMDM from wt and IFNAR1
2/2 mice were stimulated
for 6 h and RNA were subjected to qRT-PCR. As expected, T.
whipplei induced a marked expression of these genes (Fig. 4E).
However, the absence of type-I IFN receptor, which blocks the
type I IFN autocrine induction, dramatically inhibited irg1, ifit1,
ifit2, ifit3, mx1 and mx2 gene induction by T. whipplei (Fig. 4E).
Finally, only live bacteria induced type I response, as heat-killed
forms of T. whipplei did not induce transcription of ifnb1, irg1, ifit1,
ifit2, ifit3, mx1 and mx2 (Fig. 4F).
Overall, these results indicate that type I IFN response is
induced by viable T. whipplei organisms and likely involves a type I
IFN autocrine loop.
Type I IFN-dependent MAPK signalling in T. whipplei
infected BMDM
As members of the MAPK family are activated following the
engagement of the type I IFN receptor and participate in the
generation of IFN signals [28], we treated BMDM with T. whipplei
Figure 3. T. whipplei replicates in BMDM. (A) BMDM were infected with T. whipplei (MOI 50:1) for 4 h (uptake), washed and incubated for
different periods. Levels of bacterial DNA copy number were determined by qPCR (n=3). (B) At day 12 post infection, T. whipplei organisms, lamp-1
and cathepsin D were visualized by laser scanning microscopy.
doi:10.1371/journal.ppat.1000722.g003
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state at 24 h and 48 h. Interestingly, we found that p38, ERK and
JNK were phosphorylated at 24 h and their phosphorylation
remained detectable 48 h after T. whipplei infection (Fig. 5A). In
order to examine whether this late MAPK induction was
attributable to type I IFN signalling, we monitored the activation
of p38, ERK and JNK in IFNAR1
2/2 BMDM. After stimulation
with T. whipplei, p38 and ERK activities were increased at 24 h
and were still detectable at 48 h (Fig. 5A). Conversely, the
immunoreactive band of phospho-JNK was poorly if not detected
in IFNAR1
2/2 BMDM stimulated for 24 h and 48 h (Fig. 5A).
Densitometry of the phosphorylated p38, ERK and JNK 24-h
Figure 4. T. whipplei induces a functional type I IFN response. (A) RAW cells were transiently transfected with IRF3-EGFP before stimulation
with T. whipplei (MOI 50:1) for 4 h. Nuclei were stained with DAPI. (B) RAW cells were transiently transfected with IRF3-specific siRNA (si-IRF3), control
scramble siRNA (si-SCR) or left untransfected (control) 24 h before stimulation with T. whipplei (MOI 50:1). IFN-b expression was monitored after 6 h
using qRT-PCR. Results are expressed as the ratio of expression levels in infected cells vs. uninfected cells relative to b actin). (C) BMDM from wild-type
and MyD88/TRIF
2/2 mice were stimulated with T. whipplei (MOI 50:1) for 6 h and IFN-b expression was monitored using qRT-PCR. Results are
expressed as the ratio of expression levels in infected cells vs. uninfected cells relative to b actin). (D) BMDM from wild-type and IFNAR1
2/2 mice were
stimulated for indicated time points with T. whipplei (MOI 50:1), and lysates were analyzed by immunoblotting. Phospho-STAT1 blots were stripped
and reprobed for p38 as loading control. One representative experiment is shown (n=3). (E) BMDM from wild-type and IFNAR1
2/2 mice were
stimulated with T. whipplei (MOI 50:1) for 6 h and host responses were monitored using qRT-PCR on indicated genes. Results are expressed as the
ratio of expression levels in infected cells vs. uninfected cells relative to b actin). (F) BMDM were stimulated with live and heat-killed T. whipplei (MOI
50:1) for 6 h and host responses were monitored by qRT-PCR on indicated genes. Results are expressed as the ratio of expression levels in infected
cells vs uninfected cells relative to beta actin.
doi:10.1371/journal.ppat.1000722.g004
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(Fig. 5B). These results suggest that T. whipplei induces a late
MAPK signalling, which is, at least for JNK, dependent on the
type I IFN receptor engagement.
Type I IFN signalling sensitizes BMDM to cell death
following T. whipplei infection
Type I IFNs are known to induce apoptosis, at least in part
through up-regulation of tumor necrosis factor (TNF) family
proteins such as CD95 (Fas) [29]. In addition, we previously
showed that T. whipplei induces apoptosis of human macrophages
and that circulating apoptotic markers are increased during active
Whipple’s disease [22,23]. To explore whether T. whipplei induces
apoptosis of BMDM and whether type I IFN was involved, we
measured BMDM apoptosis by TUNEL assay in time course
experiments. We observed a gradual increase of TUNEL-positive
cells that peaked at 18 h post infection, with nearly 25% of
apoptotic cells (Fig. 6A and 6B). Thereafter, the number of
apoptotic cells slightly decreased and remained stable at 15%,
48 h post infection (Fig. 6B). Interestingly, double-labeling of the
apoptotic nuclei and T. whipplei in BMDM revealed that apoptosis
was induced in infected cells, but also in cells that had not engulfed
bacteria (Fig. 6A, arrow).
In IFNAR1
2/2 BMDM, T. whipplei-induced apoptosis at 18 h
was significantly reduced as compared to wt BMDM (Fig. 6C).
This was not due to delayed apoptosis since incubating cells for
longer periods did not reveal significant changes in cell death (data
not shown). In addition, UV exposure of IFNAR1
2/2 BMDM
induced cell apoptosis at a level comparable to that of UV-treated
wt BMDM (Fig. 6C), ruling out the fact that the IFN receptor
would have been required for apoptosis induction.
Some studies have demonstrated that JNK plays a pivotal role
in the activation of the apoptotic pathways [30]. As JNK was not
activated and apoptosis was significantly reduced in T. whipplei-
infected IFNAR1
2/2 BMDM (see Fig. 5A and 6C), we wondered
if JNK was required for T. whipplei-induced BMDM apoptosis.
BMDM from wt mice were treated with the JNK specific inhibitor
SP600125 for 30 min prior T. whipplei infection and apoptosis was
measured after 18 h. We found that JNK inhibition significantly
prevented T. whipplei-induced apoptosis (Fig. 6D). Taken together,
these results confirm that the transcriptional proapoptotic pattern
induced by T. whipplei is functional and indicate that T. whipplei-
induced apoptosis is dependent on an autocrine/paracrine loop
involving type I IFN, its receptor IFNAR1 which leads to JNK
activation.
Type I IFN is associated with T. whipplei replication
Puzzled by these findings, we wondered if bacterial replication
was linked to type I IFN signaling. Thus, we infected BMDM from
IFNAR1
2/2 mice with T. whipplei for 4 h and assessed bacterial
replication. As expected, results showed that the type I IFN
receptor was not involved in bacterial uptake, as around 7,000
bacterial DNA copies were detected after 4 h infection (Fig. 7A),
which were comparable to that found in wt BMDM (Fig. 3A).
However, replication of T. whipplei was reduced in these BMDM:
around 10,000 bacterial DNA copies were detected at day 12
(Fig. 7A, compare with Fig. 3A, 30,000 copies at day 12),
suggesting that type I IFN-dependent signaling is involved in
macrophage permissivity to T. whipplei. Interestingly, we found
that the killing of T. whipplei in IFNAR1
2/2 BMDM was
associated with the maturation of T. whipplei-containing phago-
somes, as T. whipplei colocalized with both Lamp1 and cathepsin D
(85%614% and 97%65%, respectively) at day 12 (Fig. 7B).
Finally, we wondered if type I IFN, JNK activation and bacterial
replication were related. Hence, BMDM from wt mice were
treated with a JNK-specific inhibitor. Bacterial survival and the
nature of T. whipplei-containing phagosome were monitored by
qPCR and confocal microscopy, respectively. JNK inhibition
revealed cellular toxicity beginning at day 6. However, during the
first 6 days, bacterial replication was similar in untreated and
SP600125-treated BMDM (Fig. S3A). In addition, most bacteria
colocalized with lamp1 (83%613%), but not with cathepsin D
(5%63%) at day 6 in both untreated and SP600125-treated
BMDM (Fig. S3B). Overall, these results showed that T. whipplei-
induced type I IFN response governs bacterial replication through
modulation of the phagosome conversion, independently of JNK
activation.
Discussion
A key requirement for dissecting the complex role of
macrophages during infection is to understand how microbes
activate or regulate host cells. In this study, we examined and
characterized host responses induced by the facultative intracel-
lular pathogen T. whipplei.
Using microarray analysis of bone marrow-derived macrophag-
es, we identified 59 genes that were significantly up-regulated upon
infection. By bioinformatical approach, we found that most
prominent GO groups covered immune response and cell
Figure 5. Late MAPK signaling partly depends on type I IFN
receptor. (A) BMDM from wild-type and IFNAR1
2/2 mice were
stimulated with T. whipplei (MOI 50:1) for indicated time points, and
lysates were analyzed by immunoblotting. Phospho-p38, phospho-ERK
and phospho-JNK blots were stripped and reprobed for tubulin as
loading controls. One representative experiment is shown (n=3). (B)
Densitometry values of the phospho-p38, phospho-ERK and phospho-
JNK autoradiographs were normalized to tubulin.
doi:10.1371/journal.ppat.1000722.g005
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represented genes could be classified in 4 functional categories.
First, we found that T. whipplei induced M2 polarization of
BMDM, which is consistent with the transcriptional profile of
intestinal infiltrating cells, mainly comprised of macrophages, from
patients with Whipple’s disease [24]. Arginase, the M2 chemokines
Ccl22 and Ccl17, and the IL-1 receptor antagonist were induced
in macrophage following infection as it has been described in
Whipple’s disease lesions [24]. M2 macrophages differ from
classically activated M1 macrophages in terms of receptors,
cytokine/chemokine expression, and effector functions. As a
result, while M1 macrophages are microbicidal and inflammatory,
M2 macrophages are rather seen as immunomodulators with
diminished microbicidal activities [3]. We show that T. whipplei
was able to invade and replicate within BMDM in a similar
fashion to that observed in human macrophages [22], suggesting
that i) mouse macrophages constitute model cells to study T.
whipplei – macrophage interaction and ii) T. whipplei-induced M2
polarization is a general response to this pathogen. Macrophage
PRR responsible for T. whipplei recognition are still unknown.
However, TLR2 and FPR2, which encodes the mouse homolog
formyl peptide receptor 2 of the human G-protein-coupled formyl
peptide like receptor 1 were upregulated upon T. whipplei infection.
TLR2 has been shown to be overexpressed in intestinal lesions of
Whipple’s disease [24]. Recently, TLR2 and the intracellular
receptor nucleotide-binding oligomerization domain 2 (Nod2)
have been shown to cooperate in inducing the expression of FPR2
in microglial cells [31]. As FPR2 mediates the chemotactic activity
of a variety of pathogen and host-derived peptides, it may actively
participate in the macrophage infiltration observed in Whipple’s
disease lesions.
Second and more strikingly, we found that a robust type I IFN
response was induced by viable T. whipplei. As compared with the
plethora of reports delineating the critical role of type I IFN in host
resistance to many types of viruses, only few papers report their
involvement during bacterial infections [32]. Results from our
study suggest that type I IFN is induced in a MyD88-/TRIF-
dependent pathway and demonstrate that, comparable to classical
type I IFN triggering signals [33], IRF3 signaling is activated
following T. whipplei infection. Activation of the transcription
factor IRF3 is likely to be dependent on TBK1. Indeed, TBK1 is
required for the activation and nuclear translocation of IRF3 in
mouse embryonic fibroblasts (MEF). Moreover, Tbk1
2/2 MEF
show marked defects in type I IFNs, Cxcl10, and RANTES gene
expression after infection with either Sendai or Newcastle disease
viruses or after engagement of the TLR3 and TLR4 by double-
stranded RNA and LPS, respectively [34]. To our knowledge, type
I IFNs have never been associated with the induction of M2
Figure 6. T. whipplei-induced apoptosis depends on type I IFN through JNK activity. (A) BMDM were infected with T. whipplei (MOI 50:1) for
4 h and incubated for the indicated times. Apoptotic cells were revealed by TUNEL reaction, while T. whipplei organisms were revealed using a T.
whipplei specific antibody. Nuclei were stained with DAPI. (B) Apoptosis was quantified by examining 3 to 5 fields per condition (100 to 300 cells
each). The percentage of TUNEL-positive cells was calculated as the ratio between TUNEL-positive and DAPI-stained nuclei 6100 (white bars:
uninfected cells, black bars: T. whipplei-infected cells, gray bar: DNaseI-treated cells). (C) BMDM from wild-type and IFNAR1
2/2 mice were infected
with T. whipplei (MOI 50:1) for 4 h and incubated for 18 h. As a control, cells were exposed to UV. Apoptosis was determined as the percentage of
TUNEL-positive cells. (*, P,0.05). (D) BMDM were treated or not with the JNK specific inhibitor SP600125 for 30 min. Cells were then infected with T.
whipplei (MOI 50:1) for 4 h and incubated for 18 h. Apoptosis was determined as the percentage of TUNEL-positive cells. (*, P,0.05).
doi:10.1371/journal.ppat.1000722.g006
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[35]. However, our results strongly support this new association as
data presented here suggest a positive feedback loop involved in
BMDM response to T. whipplei. First, STAT1 was phosphorylated
on Y701, and this phosphorylation was absent when we used
IFNAR1
2/2 BMDM. It has been shown that Stat1 activation is
achieved by phosphorylation on Y701 that is followed by nuclear
accumulation. For full transcriptional activity, Stat1 is also
phosphorylated on S727 [36]. As T. whipplei induced the
expression of several IFN inducible genes, it is likely that STAT
was also phosphorylated on S727. Second, we found that the
transcription of these IFN inducible genes was abolished when
macrophages lacking the type I IFN receptor were used.
Our microarray analysis did not reveal any genes related to
proinflammatory activities of macrophages, suggesting that T.
whipplei is a weak inducer of inflammatory responses. Even if T.
whipplei triggered a weak IkBa degradation, RelA translocation in
the nucleus was not detected, despite strong translocation when
cells were treated with LPS. This may be due to the lack of
sensitivity of the immunofluorescence assay since IkBa, the gene of
which is under the control of NF-kB is resynthetized and reached
initial values by 3 h. Consistent with the weak activation properties
of T. whipplei, we were not able to detect early MAPK signaling in
macrophages. However, MAPKs were activated more lately, after
24 h. The kinetics of MAPKs activation suggest that p38, ERK
and JNK might be activated by a secondary signal, emanating
from the initial T. whipplei-macrophage interaction. Indeed, type I
IFN receptor engagement for example, has been shown to induce
MAPKs [37,38]. Nevertheless, we found that only JNK phos-
phorylation was absent in IFNAR1
2/2 BMDM, while activation
of p38 and ERK was similar to that observed in their wt
counterparts.
Another interesting feature of the T. whipplei - macrophage
interaction revealed by this study is the induction of apoptosis.
Macrophage apoptosis is probably linked to bacterial replication.
Indeed, cells that are able to eliminate T. whipplei such as
monocytes do not undergo apoptosis [22]. These results are
strengthened by the fact that circulating levels of apoptotic
markers such as nucleosomes are increased in patients with active
Whipple’s disease [23]. Here, T. whipplei induced BMDM
apoptosis with a maximal response 18 h post infection, while
heat-killed bacteria were unable to induce apoptosis (data not
shown). Induction of apoptosis appeared associated with i) type I
IFN response and ii) JNK signaling. Apoptosis was inhibited by
around 60% when IFNAR1
2/2 BMDM were infected with T.
whipplei. In the meantime, JNK activation was abrogated in these
cells. By using a JNK-specific inhibitor, we were also able to inhibit
by 50% T. whipplei-induced apoptosis. Hence, we can hypothesize
that T. whipplei induces type I IFN, which binds its receptor,
induces JNK phosphorylation to promote macrophage apoptosis.
Recently, Jeon and colleagues have shown that type I IFNs
activate a JNK-specific signaling cascade involving Rac1,
MEKK1, MKK4 and leading to apoptosis through filamin B
[39]. Type I IFNs have also been shown to activate JNK for the
induction of apoptosis in some lymphoma cells [40]. Finally, type I
IFNs also activate the caspase cascade leading to apoptosis [41].
However, we cannot rule out the hypothesis that macrophage
apoptosis arise from other signals. Indeed, we found that genes
encoding Fas (CD95/Apo1) and Tnfsf10 (TNF-related apoptosis-
inducing ligand, TRAIL/Apo2L) were both significantly induced
in BMDM in response to T. whipplei. Besides TNF itself, Fas and
Tnfsf10 constitute two of the three death receptor/ligand systems
that are responsible for the extrinsic induction of cell death [42].
Interestingly, Fas and Tnfsf10-dependent pathways involve JNK
signaling and have been implicated in immunosuppressive and
immunoregulatory functions [42,43].
Besides its role on apoptosis induction, type I IFN appeared to
be involved in replication of T. whipplei. Bacterial replication was
partly inhibited in IFNAR1
2/2 cells, as compared with wt
BMDM. We also found that in wt BMDM, bacteria colocalized
with Lamp1 but not with cathepsin D, as already described [44].
In contrast, in macrophage lacking the type I IFN receptor,
bacteria mostly colocalized with cathepsin D. These results suggest
that type I IFN can modulate, at least in part, microbial killing.
Indeed, it has been shown that type I IFNs modulate vacuolar H
+-
ATPase-mediated acidification [45]. Interestingly, JNK activation
was not required for T. whipplei replication and alteration of
phagosome maturation. The role of JNK in phagosome
conversion and bacterial killing is unclear as it seems to depend
both on the upstream events (engaged receptor) and the pathogen
itself. Indeed, it has been shown that JNK is involved in
Staphylococcus aureus killing in a TLR2-dependent pathway through
generation of superoxide, while its inhibition has no effect when
cells are infected with E. coli [46]. From our study, two signals are
emanating from the type I IFN receptor. The first involves JNK
and leads to macrophage apoptosis while the second promotes
alteration of phagosome maturation and bacterial replication
independently of JNK. It has been shown that stimulation with
type I IFN activates phosphatydilinositol-3 kinase (PI3K) and its
downstream effectors [47]. As PI3K is involved in the modulation
of phagosome maturation [48], it is therefore possible that PI3K
activity is modulated by T. whipplei to alter its phagosome and to
favour its replication. Further studies are needed to determine
from where these two signals diverge.
A growing body of evidence shows that type I IFN participate in
the host response to bacterial infection. However, their effects to the
host can be either favorable or detrimental. For example, type I IFN
response is critical in protecting the host against the extracellular
Figure 7. T. whipplei replication is impaired in IFNAR1
2/2
BMDM. (A) BMDM from IFNAR1
2/2 mice were infected with T. whipplei
(MOI 50:1) for 4 h (uptake), washed and incubated for different periods.
Levels of bacterial DNA copy number were determined by qPCR (n=3).
(B) At day 12 post infection, T. whipplei organisms, Lamp-1 and
cathepsin D were visualized by laser scanning microscopy.
doi:10.1371/journal.ppat.1000722.g007
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type I IFN during L. monocytogenes infection sensitizes macrophages to
cell death [49]. Similarly, type I IFN production also appears
detrimental for the host during infection with the T. whipplei-closely
related M. tuberculosis [50]. M. bovis was shown to have enhanced
replication rates in macrophages treated with type I IFN [51]. Our
results suggest that the type I IFN induced by T. whipplei is
detrimental for macrophages. Human infection with T. whipplei is a
rare event despite the environmental ubiquity of the organism.
Clinical features of Whipple’s disease are non specific and it is clear
that identifying the molecular mechanisms involved in type I IFN
responses would have both clinical and therapeutic consequences.
Materials and Methods
Mice, cell culture and bacteria
BMDM from six week-old C57BL/6 and IFNAR1
2/2 [52]
mice were isolated as described previously [53]. Double MyD88/
TRIF-deficient mice were bred from MyD88
2/2 [54] and
LPS2
2/2 [55] mice. Mouse RAW 264.7 macrophages (American
Type Culture Collection, ATCC Nu TIB-71) were grown in
Dulbecco’s Modified Eagle Medium (DMEM) high glucose
containing 10% FCS.
The strain Twist-Marseille of T. whipplei (CNCM I-2202) was
cultured with HEL cells and purified as described previously [22].
Heat-killed T. whipplei was prepared by heating at 80uC for 1 h. All
animal experiments followed the guiding principles of animal care
and use defined by the Conseil Scientifique du Centre de
Formation et de Recherche Experimental Me ´dico-Chirurgical
(CFREMC) and were approved by the ethics board of the
university at which the experiments were performed (Faculte ´d e
Me ´decine de la Timone).
Statistical analysis
All experiments were performed at least three times. One
representative experiment is shown. Error bars represent SD of
triplicate values from a representative experiment. *, P,0.05,
Mann-Whitney’s U test.
Transient transfection
The eGFP-IRF3 plasmid was kindly provided by G. Querat
(Marseille, France). RAW 264.7 macrophages were transfected
with eGFP-IRF3 plasmid construct using Nucleofactor (Amaxa
Biosystems), according to the manufacturer’s recommendations.
IRF3-specific and control scramble siRNA were purchased
from Santa Cruz Biotechnology. RAW 264.7 macrophages were
transfected with IRF3-specific and control siRNA using Nucleo-
factor (Amaxa Biosystems), according to the manufacturer’s
recommendations.
Macrophage infection and real-time quantitative PCR
(qPCR)
T. whipplei organisms (MOI 50:1) were added to BMDM for 4 h,
washed to remove free bacteria and incubated for 12 days in
RPMI 1640 containing 10% FCS and 2 mM glutamine. Every 3
days, macrophages were collected and DNA was extracted using
the QIAamp DNA MiniKit (Qiagen). PCR was performed using
the LightCycler-FastStart DNA Master SYBR Green system
(Roche), as previously described [22].
Immunofluorescence
Macrophages seeded on glass coverslips were infected with T.
whipplei (MOI 50:1) for 4 h, extensively washed to discard
unbound bacteria and incubated in RPMI 1640 containing 10%
FCS. At different time points, BMDM were fixed in 3%
paraformaldehyde and permeabilized with 0.1% Triton X-100.
Immunofluorescence labeling was performed according to stan-
dard procedures [56]. Briefly, BMDM were incubated with rabbit
anti-T. whipplei (1:2,000 dilution) antibodies (Ab) for 30 min [44]
and rat anti-lamp1 (1:1,000 dilution, clone 1D4B, purchased from
DSHB) or rabbit anti-cathepsin D (1:1,000 dilution, a gift from S.
Kornfeld, Washington University School of Medicine, St. Louis,
Missouri). Secondary Alexa Abs were purchased from Invitrogen
and used at a 1:500 dilution. Coverslips were mounted with
Mowiol and examined by laser scanning microscopy using a
confocal microscope (Leica TCS SP5) with a 63X/1.32-0.6 oil
objective and an electronic Zoom 2X. Optical sections of
fluorescent images were collected at 0.15-mm intervals using Leica
Confocal Software and processed using Adobe Photoshop V7.0.1.
For the assessment of RelA (p65) translocation in the nucleus,
the same procedure was followed except that BMDM were
incubated with rabbit anti-p65 (RelA) monoclonal Ab (Cell
Signaling).
ELISA
Cell culture supernatants were assayed for IFN-b by ELISA
(R&D Systems) according to the manufacturer’s instructions.
Microarray analysis
BMDM were infected with T. whipplei for 6 h (MOI 50:1) and
total RNA was extracted using the RNeasy minikit (Qiagen). The
quality and the quantity of RNA preparation were assessed using
the 2100 Bioanalyzer (Agilent Technologies). The 4X44k Mouse
Whole Genome microarrays (Agilent Technologies) were used.
Sample labeling and hybridization were performed according to
the manufacturer recommendations (One-Color Microarray-
Based Gene Expression Analysis). Briefly, 300 ng of total RNA
and cyanine 3-labeled CTP were used to synthesize labeled cRNA
using the Low RNA Input Fluorescent Amplification Kit (Agilent
Technologies). Hybridizations were performed in triplicates for
17 h at 65uC using the In situ Hybridization Kit Plus (Agilent
Technologies). Slides were scanned at 5 mm resolution with a
G2505B DNA microarray scanner (Agilent Technologies). Image
analysis and intra-array signal correction were performed using
Agilent Feature Extractor Software 9.5.1.1. Global normalization
by trimmed means was applied on raw datasets using Excel
(Microsoft). Discrimination between samples was performed using
the unpaired Student’s t test. We only considered a gene as
differentially expressed if the P value from Student’s t test was
below 0.01 and its absolute fold change was over 2.
To identify functional categories of genes that were over-
represented in the data sets of modulated genes, we assigned Gene
Ontology (GO) annotation by using the freely available online
tools FatiGO Search (http://babelomics.bioinfo.cipf.es/) and
DAVID Bioinformatics Resources 2008 (http://david.abcc.
ncifcrf.gov/).
All transcriptional profile files have been submitted to the GEO
database at NCBI (accession number GSE16180).
Quantitative real-time RT-PCR
cDNA wassynthesizedfrom 1 mg of totalRNAusing SuperScript
II RNase H reverse transcriptase (Invitrogen). Specific primers for
each gene were designed using Primer3Plus, available online at
http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.
cgi. The sequences of the targeted genes are listed in Table 2.
Quantitative RT-PCR was performed using LightCycler-Fastart
DNA Master SYBR Green (Roche Diagnostics) and data acquired
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expression was normalized to the b-actin gene, relative expression
of respective genes was calculated using comparative threshold
cycle method [57].
Western blotting
Macrophages were stimulated with either T. whipplei (MOI
50:1) or Escherichia coli 055:B5 LPS (100 ng/ml, Sigma). At
designated times, BMDM were washed with ice-cold PBS. Cells
were then scrapped in ice-cold RIPA buffer (20 mM Tris-HCl,
200 mM NaCl, 1 mM EDTA, 1% Triton-X100, pH 7.5)
containing protease inhibitor (Complete, Roche) and phospha-
tase inhibitor (Phosphostop, Roche) cocktails. The cell lysates
were cleared by centrifugation at 14,000 rpm for 15 min at 4uC
a n ds t o r e da t280uC. Cell lysates were examined for equal
amounts of protein by the Bradford method using c globulin as
a standard [58]. Samples were loaded onto 10% sodium dodecyl
sulfate polyacrylamide gels, electrophoresed and transferred
onto nitrocellulose membranes (Amersham). The membranes
were blocked in PBS with 0.05% Tween 20 (PBST) supple-
mented with 3% powdered milk and then incubated with
primary Abs against phospho-p38, total p38, phospho-ERK1/
2, total ERK1/2, phospho-JNK, a-tubulin (Cell signaling),
IkBa (Calbiochem) or IRF3 Ab (Santa Cruz) as indicated
by manufacturers. The blots were washed with PBST and
incubated with a secondary Ab, either horseradish peroxidase-
conjugated anti-rabbit or anti-mouse immunoglobulin (Pierce)
in PBST plus 3% powdered milk. The bound Abs were detected
using Immobilon Western Chemiluminescent HRP substrate
(Millipore).
Apoptosis determination by Terminal transferase
deoxytidyl uridine end labeling (TUNEL) staining
Detection of apoptosis by TUNEL was performed using In Situ
Cell Death Detection Kit, TMR red (Roche) according to the
manufacturer’s instructions. JNK inhibition was performed using
SP600125 (Sigma) at 50 mM for 30 min prior infection. As a
control, apoptosis was induced by exposing cells to ultraviolet (UV)
as described previously [59]. After treatment as indicated, cells on
glass coverslips were fixed in 4% paraformaldehyde for 15 min,
washed in PBS and permeabilized with 0.1% Triton-X100 in
0.1% sodium citrate for 2 min. Cells were then incubated with the
TUNEL mixture containing TMR-dUTP and terminal deoxynu-
cleotidyl transferase for 1 h. Cells were washed in PBS and nuclei
were stained with DAPI before mounting with Mowiol. Positive
controls were carried out by incubating cells with 3 U/ml DNase I
prior labeling procedures. Negative controls were done by
incubating cells with label solution (without terminal deoxynu-
cleotidyl transferase). Apoptosis was quantified as follows.
Coverslips were examined in fluorescence mode with a Leica
microscope equipped with a Nikon digital camera using a 10X
objective lens. Three to five fields per condition (100 to 300 cells
each) were observed. The number of TUNEL-positive and DAPI-
stained nuclei were determined and the apoptosis percentage was
expressed as the ratio between TUNEL-positive and DAPI-stained
nuclei 6100.
List of LocusLink accession numbers for genes and
proteins mentioned in the text
arg2, 11847; ccl17, 20295; ccl22, 20299; clec4e, 56619; cxcl10,
15945; fas, 14102; fpr2, 14289; gbp2, 14469; ifi44, 99899; ifit1,
15957; ifit2, 15958; ifit3, 15959; ifnar1, 15975; ifnb1, 15977; il1rn,
16181; irf3, 54131; irg1, 16365; mx1, 17857; mx2, 17858; myd88,
17874; olr1, 108078; tlr2, 24088; tnfsf10, 22035; trif (ticam1),
106759.
Supporting Information
Figure S1 Time course of IFN-b expression and production in
BMDM. (A) BMDM were stimulated with T. whipplei (MOI 50:1)
for the indicated time points and IFN-b expression was monitored
using qRT-PCR. Results are expressed as the ratio of expression
levels in stimulated cells vs. uninfected cells relative to b actin. (B)
BMDM were stimulated with T. whipplei (MOI 50:1) for the
indicated time points and cell supernatants were assessed for IFN-
b by ELISA (n=3).
Found at: doi:10.1371/journal.ppat.1000722.s001 (0.27 MB PDF)
Figure S2 IRF3 knock-down efficiency. (A) RAW cells were
transiently transfected with IRF3-specific siRNA (si-IRF3),
control scramble siRNA (si-SCR) or left untransfected (control).
After 24 h and 48 h, lysates were analyzed by immunoblotting.
IRF3 blots were stripped and reprobed for tubulin as loading
controls. Densitometry values of the IRF3 autoradiographs
were normalized to tubulin. (B) RAW cells were transiently
transfected with IRF3-specific siRNA (si-IRF3), control scram-
ble siRNA (si-SCR) or left untransfected (control) 24 h before
stimulation with T. whipplei (MOI 50:1). After 6 h, cell
supernatants were harvested and IFN-b production was
assessed by ELISA (n=3).
Found at: doi:10.1371/journal.ppat.1000722.s002 (0.56 MB PDF)
Figure S3 Bacterial replication proceeds independently of
JNK activation. (A) BMDM were treated or not with the JNK
specific inhibitor SP600125 for 30 min. Cells were then
infected with T. whipplei (MOI 50:1) for 4 h. SP600125 was
added during the infection procedure. Levels of bacterial DNA
copy number were determined by qPCR (n=3). (B) At day 6
post infection and in the presence of SP600125, T. whipplei
organisms, lamp-1 and cathepsin D were visualized by laser
scanning microscopy.
Found at: doi:10.1371/journal.ppat.1000722.s003 (0.68 MB PDF)
Table 2. Primers used.
Target Upstream primer (59 R 39) Downstream primer (59 R 39)
mmp14 CCCAGATAAGCCCAAAAACC GCATTGGGTATCCATCCATC
irg1 TTCCAAGCCTGGATTCTCAC TCACAAGGTGCTTTCTCACG
ifit2 TACCCATCAGCAAGATGCAC CTGTGTCAAAGCGCTCAAAG
arg2 TGGATCAAACCTTGCCTCTC GCCGATCAAATGTCTGTTCC
ifi44 GCATATGCTGCATTGTCACC TCCATTCCCAGTCCTTTCAG
ccl22 TCCCAGGGGAAGGAATAAAC TTGTGGTCCCATATGCTGTC
ifit1 ATGGGAGAGAATGCTGATGG CCCAATGGGTTCTTGATGTC
olr1 TGGCTATGGGAGAATGGAAC CAGTTTTCAGCGAACACAGC
nfkbie AAGGATTGCAGACGAGGAAG ATCCCCATTTTCCAGGTAGC
ccl17 AAAGGGGCCATTCCTATCAG CCAATCTGATGGCCTTCTTC
mx2 AGACAAAGCATGGCACTTCC ACTGGATGATCAAGGGAACG
mx1 TGCTCATCTCCGACTGTTTG TGGGGTACACAGGTGAAATG
Ifnb1 CCCTATGGAGATGACGGAGA TCCCACGTCAATCTTTCCTC
actb TGGAATCCTGTGGCATCCATG-
AAAC
TAAAACGCAGCTCAGTAACAG-
TCCG
These primers were designed using the primer3 tool available at the following
website: http://frodo.wi.mit.edu/.
doi:10.1371/journal.ppat.1000722.t002
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